Prosecution Insights
Prosecution Insights
Tech Center 1600 • Art Units: 1626
This examiner grants 71% of resolved cases
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18375697 | COMPOSITIONS AND METHODS FOR TREATING OCULAR CHEMICAL BURNS | Non-Final OA | OHIO STATE INNOVATION FOUNDATION |
| 18039188 | COMPOUND, ORGANIC ELECTROLUMINESCENCE DEVICE AND ELECTRONIC APPARATUS | Non-Final OA | IDEMITSU KOSAN CO.,LTD. |
| 18455029 | PYRIMIDIN-2-YL SULFONAMIDE DERIVATIVES | Non-Final OA | Hoffmann-La Roche Inc. |
| 18030935 | Antibacterial And Deodorizing Composition, And Preparation Method Therefor | Non-Final OA | LG Chem, Ltd. |
| 18123018 | Circularly Recyclable Polymers Featuring Topochemically Elongated Carbon-Carbon Bonds | Non-Final OA | Purdue Research Foundation |
| 17840633 | METAL-PHOSPHORIZED CATALYST FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID AND METHOD FOR PRODUCING 2,5-FURANDICARBOXYLIC ACID USING THE SAME | Final Rejection | KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY |
| 18015746 | MONOTERPENOID AND PHENYLPROPANOID CARBONATE ESTERS AND METHODS OF THEIR MAKING AND USE AS REPELLENTS | Non-Final OA | IOWA STATE UNIVERSITY RESEARCH FOUNDATION, INC. |
| 18325264 | PROCESS FOR PRODUCING FURFURAL FROM BIOMASS | Non-Final OA | UOP LLC |
| 18279815 | PYRIMIDINE OR PYRIDINE DERIVATIVES USEFUL AS HCN2 MODULATORS | Non-Final OA | King's College London |
| 18555112 | COMPOSITIONS AND METHODS FOR THE TREATMENT AND PREVENTION OF CANCER | Non-Final OA | Yale University |
| 18626788 | PROCESS FOR PREPARING SUBSTITUTED CYCLOHEXANE AMINO ACID ESTERS AND SPIROKETAL-SUBSTITUTED CYCLIC KETO-ENOLS | Final Rejection | Bayer Aktiengesellschaft |
| 18113206 | TRIFUNCTIONAL CONSTRUCTS WITH TUNABLE PHARMACOKINETICS USEFUL IN IMAGING AND ANTI-TUMOR THERAPIES | Non-Final OA | Cornell University |
| 18758924 | Compositions And Methods Targeting G12 Signaling For Bronchodilator Therapy | Non-Final OA | Rutgers, The State University of New Jersey |
| 18036095 | PHENOTHIAZINE COMPOUNDS FOR THE TREATMENT OF ALZHEIMER'S DISEASE AND OTHER AGE-RELATED AND NEUROLOGICAL DISEASES | Non-Final OA | Icahn School of Medicine at Mount Sinai |
| 18552715 | COMPOSITION FOR AMELIORATING OR SUPPRESSING DECLINE OF KIDNEY FUNCTIONS | Non-Final OA | SUNTORY HOLDINGS LIMITED |
| 18569867 | BENZOXAZINONE DERIVATIVES | Non-Final OA | MEDSHINE DISCOVERY INC. |
| 18519533 | COMPOUNDS AND USES THEREOF | Non-Final OA | FOGHORN THERAPEUTICS INC. |
| 18557449 | SYNTHESIS OF CBN AND CBNV | Non-Final OA | TEEWINOT LIFE SCIENCES CORPORATION |
| 18275929 | GLOBODERA PALLIDA CONTROL AGENT | Non-Final OA | Nippon Soda Co., Ltd. |
| 18458420 | BIOACTIVE EXTRACTION METHOD | Non-Final OA | Performance Labs Pte. Ltd. |
| 17776870 | A CONTINUOUS PROCESS FOR THE SYNTHESIS OF AZO DYES INVOLVING IN-SITU GENERATION OF DIAZONIUM SALTS | Non-Final OA | Council of Scientific and Industrial Research |
| 17802827 | COMPOUNDS AND METHODS FOR MODULATING SPLICING | Final Rejection | REMIX THERAPEUTICS INC. |
| 18027005 | COMPOUNDS AND COMPOSITIONS AS MODULATORS OF TLR SIGNALING | Non-Final OA | Neuropore Therapies, Inc. |
| 18007199 | Novel Compounds for Treating Fibrosis and Inflammatory Conditions | Non-Final OA | MAKScientific, LLC |
| 17390064 | CONJUGATION OF A CYTOTOXIC DRUG WITH BIS-LINKAGE | Final Rejection | Hangzhou DAC Biotech Co., Ltd. |
| 17593380 | CAPTURE OF MICROVESICLES FOR DIAGNOSTIC PURPOSES | Non-Final OA | CENTRE HOSPITALIER UNIVERSITAIRE DE BORDEAUX |
| 17190177 | PROANGIOGENIC COMPOSITIONS AND METHODS OF USE | Non-Final OA | University of North Dakota |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy